优化疟疾控制的适应性干预:区块整群随机序贯多分配试验实施研究方案
该研究采用纵向区块整群序贯多分配随机试验(SMART)设计,在肯尼亚西部开展为期3年的两阶段试验,初始纳入36个整群,主要结局为临床疟疾发病率。第一阶段将整群随机分配至长效杀虫蚊帐(LLIN)、增效醚处理蚊帐(PBO Nets)或LLIN+室内滞留喷洒(IRS),随访12个月后根据发病率变化和卫生部设定的成本效果阈值评估应答与否。第二阶段对无应答者随机分配至强化干预方案,并随访18个月评估效果与成本效果。
要点
- 首个疟疾控制适应性试验,采用SMART设计动态优化干预组合。
- 第一阶段比较LLIN、PBO Nets和LLIN+IRS三种一线干预。
- 基于12个月发病率变化和成本效果阈值判定应答,调整后续干预。
核心结论
- 该适应性干预策略旨在优化现有疟疾媒介控制工具并整合新控制产品,以寻找不同环境下最具成本效果的疟疾控制策略。
研究设计与样本
- 采用纵向区块整群序贯多分配随机试验(SMART)设计,在肯尼亚西部开展为期3年的两阶段试验,初始纳入36个整群。
- 第一阶段整群按疟疾风险区块随机等概率分配至LLIN、PBO Nets或LLIN+IRS,随访12个月评估应答。
- 第二阶段无应答者随机分配至强化干预方案,随访18个月评估效果。
关键数值与推荐
- 主要结局为临床疟疾发病率。
- 应答判定基于临床疟疾发病率变化和卫生部设定的成本效果阈值。
- 第一阶段PBO Nets无应答者随机分配至PBO Nets+幼虫源头管理(LSM)或由增强强化学习方法确定的干预。
- 第一阶段LLIN+IRS无应答者随机分配至LLIN+IRS+LSM或PBO Nets+IRS。
临床怎么用
- 通过主动病例监测和光诱捕器监测室内外媒介丰度,评估干预效果。
- 使用Q学习评估干预措施的成本效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In the past two decades, the massive scale-up of long-lasting insecticidal nets (LLINs) and indoor residual spraying (IRS) has led to significant reductions in malaria mortality and morbidity. Nonetheless, the malaria burden remains high, and a dozen countries in Africa show a trend of increasing malaria incidence over the past several years. This underscores the need to improve the effectiveness of interventions by optimizing first-line intervention tools and integrating newly approved products into control programs. Because transmission settings and vector ecologies vary from place to place, malaria interventions should be adapted and readapted over time in response to evolving malaria risks. An adaptive approach based on local malaria epidemiology and vector ecology may lead to significant reductions in malaria incidence and transmission risk. METHODS/DESIGN: This study will use a longitudinal block-cluster sequential multiple assignment randomized trial (SMART) design with longitudinal outcome measures for a period of 3 years to develop an adaptive intervention for malaria control in western Kenya, the first adaptive trial for malaria control. The primary outcome is clinical malaria incidence rate. This will be a two-stage trial with 36 clusters for the initial trial. At the beginning of stage 1, all clusters will be randomized with equal probability to either LLIN, piperonyl butoxide-treated LLIN (PBO Nets), or LLIN + IRS by block randomization based on their respective malaria risks. Intervention effectiveness will be evaluated with 12 months of follow-up monitoring. At the end of the 12-month follow-up, clusters will be assessed for "response" versus "non-response" to PBO Nets or LLIN + IRS based on the change in clinical malaria incidence rate and a pre-defined threshold value of cost-effectiveness set by the Ministry of Health. At the beginning of stage 2, if an intervention was effective in stage 1, then the intervention will be continued. Non-responders to stage 1 PBO Net treatment will be randomized equally to either PBO Nets + LSM (larval source management) or an intervention determined by an enhanced reinforcement learning method. Similarly, non-responders to stage 1 LLIN + IRS treatment will be randomized equally to either LLIN + IRS + LSM or PBO Nets + IRS. There will be an 18-month evaluation follow-up period for stage 2 interventions. We will monitor indoor and outdoor vector abundance using light traps. Clinical malaria will be monitored through active case surveillance. Cost-effectiveness of the interventions will be assessed using Q-learning. DISCUSSION: This novel adaptive intervention strategy will optimize existing malaria vector control tools while allowing for the integration of new control products and approaches in the future to find the most cost-effective malaria control strategies in different settings. Given the urgent global need for optimization of malaria control tools, this study can have far-reaching implications for malaria control and elimination. TRIAL REGISTRATION: US National Institutes of Health, study ID NCT04182126 . Registered on 26 November 2019.
引用
- Zhou G, Lee MC, Atieli HE, et al. Adaptive interventions for optimizing malaria control: an implementation study protocol for a block-cluster randomized, sequential multiple assignment trial. Trials. 2020. PMID: 32690063. doi:10.1186/s13063-020-04573-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。